Form 8-K - Current report:
SEC Accession No. 0000950170-25-084244
Filing Date
2025-06-10
Accepted
2025-06-10 14:26:21
Documents
10
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vtyx-20250604.htm   iXBRL 8-K 63485
  Complete submission text file 0000950170-25-084244.txt   169347

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vtyx-20250604.xsd EX-101.SCH 24847
12 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20250604_htm.xml XML 4712
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 251036754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)